Eculizumab Biosimilar Appears Effective in Paroxysmal Nocturnal Hemoglobinuria
Researchers sought to determine whether SB12 would be a clinical equivalent to eculizumab for improving lactate dehydrogenase levels in patients with PNH.
Anemias
Impact of Policy Changes for Anemia Care in Hemodialysis Examined
Changes in anemia care associated with lower risks for major adverse cardiovascular events, stroke, mortality, heart failure.
Canakinumab Misses Primary Endpoint, But Improved Other Parameters in Patients With Sickle Cell Anemia
Researchers sought to determine whether canakinumab would reduce daily sickle cell anemia-related pain in patients with SCA.
Diagnosis and Treatment Progress in Patients With Paroxysmal Nocturnal Hemoglobinuria
Researchers sought to describe the diagnosis and treatment of patients with rare cases of PNH.
Fertility-Related Education Needed for Adolescents and Young Adults With Sickle Cell Disease
Researchers sought to determine whether fertility-related education would be needed for adolescents and young adults with SCD.
Informational Intervention Improves Hemoglobin Levels Among Pregnant Patients With Anemia
Researchers sought to determine whether an intervention package would improve clinical guidance adherence and hemoglobin levels among pregnant patients with anemia.
Anemia Trends in Reproductive-Age Women in Low- to Middle-Income Countries
Researchers sought to evaluate the rates of anemia in women of reproductive age in 15 low- to middle-income countries.
Opioid Restriction Associated With Poor Outcomes in Patients With Sickle Cell Disease
Researchers sought to evaluate the effect of the CDC’s guideline on opioid prescriptions and health outcomes on patients with SCD.
Non-Coding Genetic Variants of Pyruvate Kinase Gene Associated With Acute Pain in Sickle Cell Disease
Researchers sought to determine whether there is a link between non-coding genetic variants of PKLR and acute pain in sickle cell disease.
Thromboprophylaxis Reduces Risk of VTE for Patients With Sickle Cell Disease and a Central Venous Access Device
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...